Premium
BioCryst Pharmaceuticals Inc (BCRX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Dr. Amy E. McKeeIndependent Director | -11,18k | 100,28k | Vente | 8,97 | 18,75k | -37,35% |
| 2026-05-13 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -62,50k | 281,25k | Derivative Exercise and Sale | 5,04 - 9,54 | 147,98k | - |
| 2026-03-20 | Ms. Theresa Marie HeggieIndependent Director | -49,93k | 190,24k | Derivative Exercise and Sale | 6,30 - 10,11 | 52,85k | - |
| 2026-03-16 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -150,00k | 546,00k | Derivative Exercise and Sale | 5,51 - 9,15 | 147,98k | - |
| 2026-03-02 | Mr. Jon P. StonehouseDirector | -306,00k | 1,66M | Derivative Exercise and Sale | 3,22 - 8,64 | 1,04M | - |
| 2025-12-19 | Mr. Jon P. StonehouseDirector | -61,79k | 457,89k | Sale to Issuer | 7,41 | 1,04M | -5,63% |
| 2025-12-22 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -21,77k | 166,56k | Automatic Disposition | 7,65 | 146,03k | -12,98% |
| 2025-12-19 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -16,90k | 125,24k | Sale to Issuer | 7,41 | 146,03k | -10,37% |
| 2025-12-22 | Mr. Charles K. GayerCEO, President & Director | 74,23k | 371,90k | Derivative Exercise and Retained Stock | 3,22 - 5,51 | 361,62k | 25,83% |
| 2025-12-19 | Mr. Charles K. GayerCEO, President & Director | -11,48k | 85,04k | Sale to Issuer | 7,41 | 361,62k | -3,08% |
| 2025-12-18 | Mr. Jon P. StonehouseDirector | -20,00k | 0,00 | Other Disposition | - | 975,62k | -2,01% |
| 2025-12-12 | Mr. Charles K. GayerCEO, President & Director | -8,18k | 61,93k | Sale to Issuer | 7,57 | 258,88k | -3,06% |
| 2025-12-15 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -21,21k | 162,26k | Automatic Disposition | 7,65 | 146,03k | -12,68% |
| 2025-12-12 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -8,54k | 64,65k | Sale to Issuer | 7,57 | 146,03k | -5,53% |
| 2025-12-12 | Mr. Jon P. StonehouseDirector | -27,37k | 207,18k | Sale to Issuer | 7,57 | 975,62k | -2,73% |
| 2025-12-01 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -91,00k | 353,48k | Derivative Exercise and Sale | 3,22 - 7,10 | 146,03k | - |
| 2025-12-02 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -50,91k | 367,22k | Vente | 7,21 | 146,03k | -25,85% |
| 2025-12-03 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -19,77k | 151,24k | Automatic Disposition | 7,65 | 146,03k | -11,92% |
| 2025-11-13 | Ms. A. Machelle SandersIndependent Director | -9,60k | 68,54k | Automatic Disposition | 7,14 | 18,14k | -34,60% |
| 2025-08-13 | Ms. Theresa Marie HeggieIndependent Director | -70,00k | 292,17k | Derivative Exercise and Sale | 2,91 - 8,51 | 52,85k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
